Becton, Dickinson and (BDX) ROIC: History & Chart

Name: Becton, Dickinson and Company (BDX) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Becton, Dickinson and Company(BDX)

Medical - Instruments & Supplies · Franklin Lakes, NJ

$177.85+1.43 (+0.81%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

Compare

About Becton, Dickinson and Company

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

Franklin Lakes, NJ

72,000 employees

www.bd.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Thomas E. Polen Jr.

View full financials

BDX Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

3.72%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

4.33%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

4.11%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

4.29%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

3.78%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

5.70%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

8.11%

CURRENT VS TTM AVG

-14.03%

CURRENT VS 3Y AVG

-9.47%

CURRENT VS 5Y AVG

-13.26%

CURRENT VS 10Y AVG

-1.64%

CURRENT VS 15Y AVG

-34.73%

CURRENT VS 20Y AVG

-54.12%

SECTOR MEDIAN · HEALTHCARE

8.75%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-57.45%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Becton, Dickinson and Company (BDX)	$49.00B	3.72%	4.33%	4.11%	4.29%
Humana Inc. (HUM)vs ›	$49.21B	4.52%	3.25%	5.37%	7.01%
Edwards Lifesciences Corporation (EW)vs ›	$48.58B	10.22%	11.08%	14.46%	15.87%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$43.20B	6.79%	3.17%	0.33%	-0.73%
IQVIA Holdings Inc. (IQV)vs ›	$43.09B	8.32%	8.41%	8.23%	6.99%
Cardinal Health, Inc. (CAH)vs ›	$54.94B	13.45%	12.41%	9.39%	5.98%
Agilent Technologies, Inc. (A)vs ›	$41.50B	11.88%	12.59%	13.58%	12.74%
Moderna, Inc. (MRNA)vs ›	$57.13B	-39.16%	-31.38%	-12.74%	0.29%
IDEXX Laboratories, Inc. (IDXX)vs ›	$39.81B	41.33%	37.21%	35.10%	36.21%
Cencora, Inc. (COR)vs ›	$62.57B	12.75%	15.09%	14.58%	14.67%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Becton, Dickinson and Company (BDX)

$49.00B

3.72%

4.33%

4.11%

4.29%

Humana Inc. (HUM)vs ›

$49.21B

4.52%

3.25%

5.37%

7.01%

Edwards Lifesciences Corporation (EW)vs ›

$48.58B

10.22%

11.08%

14.46%

15.87%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$43.20B

6.79%

3.17%

0.33%

-0.73%

IQVIA Holdings Inc. (IQV)vs ›

$43.09B

8.32%

8.41%

8.23%

6.99%

Cardinal Health, Inc. (CAH)vs ›

$54.94B

13.45%

12.41%

9.39%

5.98%

Agilent Technologies, Inc. (A)vs ›

$41.50B

11.88%

12.59%

13.58%

12.74%

Moderna, Inc. (MRNA)vs ›

$57.13B

-39.16%

-31.38%

-12.74%

0.29%

IDEXX Laboratories, Inc. (IDXX)vs ›

$39.81B

41.33%

37.21%

35.10%

36.21%

Cencora, Inc. (COR)vs ›

$62.57B

12.75%

15.09%

14.58%

14.67%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The return on invested capital (ROIC) for BDX stock is 3.72%.

Is Becton, Dickinson and Company's return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 3.72% is 13% below its 5-year average of 4.29%, near the low end of its 5-year range (3.56%–5.22%).

What is the TTM average return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The TTM average return on invested capital (ROIC) for BDX stock is 4.33%.

What is the 3Y average return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The 3Y average return on invested capital (ROIC) for BDX stock is 4.11%.

What is the 5Y average return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The 5Y average return on invested capital (ROIC) for BDX stock is 4.29%.

What is the 10Y average return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The 10Y average return on invested capital (ROIC) for BDX stock is 3.78%.

What is the 15Y average return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The 15Y average return on invested capital (ROIC) for BDX stock is 5.70%.

What is the 20Y average return on invested capital (ROIC) for Becton, Dickinson and Company (BDX)?

The 20Y average return on invested capital (ROIC) for BDX stock is 8.11%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	3.72%
2026-03-31	4.10%
2025-12-31	4.75%
2025-09-30	4.73%
2025-06-30	4.33%
2025-03-31	4.09%
2024-12-31	4.41%
2024-09-30	4.03%
2024-06-30	3.69%
2024-03-31	3.56%
2023-12-31	3.56%
2023-09-30	4.11%
2023-06-30	4.33%
2023-03-31	4.27%
2022-12-31	4.32%
2022-09-30	4.42%
2022-06-30	4.47%
2022-03-31	4.41%
2021-12-31	4.40%
2021-09-30	5.22%
2021-06-30	4.61%
2021-03-31	4.28%
2020-12-31	4.12%
2020-09-30	2.69%
2020-06-30	2.71%
2020-03-31	3.27%
2019-12-31	2.88%
2019-09-30	3.71%
2019-06-30	2.71%
2019-03-31	2.63%
2018-12-31	2.58%
2018-09-30	1.68%
2018-06-30	1.97%
2018-03-31	1.27%
2017-12-31	1.76%
2017-09-30	4.27%
2017-06-30	3.29%
2017-03-31	7.75%
2016-12-31	7.59%
2016-09-30	5.86%
2016-06-30	6.39%
2016-03-31	4.95%
2015-12-31	4.39%
2015-09-30	4.22%
2015-06-30	4.26%
2015-03-31	4.80%
2014-12-31	7.53%
2014-09-30	12.01%
2014-06-30	9.88%
2014-03-31	9.63%
2013-12-31	9.72%
2013-09-30	9.79%
2013-06-30	11.77%
2013-03-31	11.92%
2012-12-31	12.00%
2012-09-30	11.99%
2012-06-30	12.51%
2012-03-31	12.17%
2011-12-31	12.23%
2011-09-30	14.52%
2011-06-30	13.28%
2011-03-31	13.24%
2010-12-31	13.34%
2010-09-30	14.06%
2010-06-30	15.64%
2010-03-31	16.21%
2009-12-31	15.76%
2009-09-30	15.40%
2009-06-30	15.78%
2009-03-31	17.87%
2008-12-31	18.13%
2008-09-30	16.82%
2008-06-30	15.92%
2008-03-31	15.61%
2007-12-31	15.82%
2007-09-30	14.12%
2007-06-30	13.19%
2007-03-31	13.01%
2006-12-31	12.42%
2006-09-30	13.83%
2006-06-30	14.15%
2006-03-31	13.75%
2005-12-31	14.41%
2005-09-30	14.25%
2005-06-30	15.59%
2005-03-31	13.97%
2004-12-31	13.84%
2004-09-30	12.81%
2004-06-30	12.45%
2004-03-31	12.68%
2003-12-31	12.61%
2003-09-30	12.42%
2003-06-30	11.81%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

3.72%

2026-03-31

4.10%

2025-12-31

4.75%

2025-09-30

4.73%

2025-06-30

4.33%

2025-03-31

4.09%

2024-12-31

4.41%

2024-09-30

4.03%

2024-06-30

3.69%

2024-03-31

3.56%

2023-12-31

3.56%

2023-09-30

4.11%

2023-06-30

4.33%

2023-03-31

4.27%

2022-12-31

4.32%

2022-09-30

4.42%

2022-06-30

4.47%

2022-03-31

4.41%

2021-12-31

4.40%

2021-09-30

5.22%

2021-06-30

4.61%

2021-03-31

4.28%

2020-12-31

4.12%

2020-09-30

2.69%

2020-06-30

2.71%

2020-03-31

3.27%

2019-12-31

2.88%

2019-09-30

3.71%

2019-06-30

2.71%

2019-03-31

2.63%

2018-12-31

2.58%

2018-09-30

1.68%

2018-06-30

1.97%

2018-03-31

1.27%

2017-12-31

1.76%

2017-09-30

4.27%

2017-06-30

3.29%

2017-03-31

7.75%

2016-12-31

7.59%

2016-09-30

5.86%

2016-06-30

6.39%

2016-03-31

4.95%

2015-12-31

4.39%

2015-09-30

4.22%

2015-06-30

4.26%

2015-03-31

4.80%

2014-12-31

7.53%

2014-09-30

12.01%

2014-06-30

9.88%

2014-03-31

9.63%

2013-12-31

9.72%

2013-09-30

9.79%

2013-06-30

11.77%

2013-03-31

11.92%

2012-12-31

12.00%

2012-09-30

11.99%

2012-06-30

12.51%

2012-03-31

12.17%

2011-12-31

12.23%

2011-09-30

14.52%

2011-06-30

13.28%

2011-03-31

13.24%

2010-12-31

13.34%

2010-09-30

14.06%

2010-06-30

15.64%

2010-03-31

16.21%

2009-12-31

15.76%

2009-09-30

15.40%

2009-06-30

15.78%

2009-03-31

17.87%

2008-12-31

18.13%

2008-09-30

16.82%

2008-06-30

15.92%

2008-03-31

15.61%

2007-12-31

15.82%

2007-09-30

14.12%

2007-06-30

13.19%

2007-03-31

13.01%

2006-12-31

12.42%

2006-09-30

13.83%

2006-06-30

14.15%

2006-03-31

13.75%

2005-12-31

14.41%

2005-09-30

14.25%

2005-06-30

15.59%

2005-03-31

13.97%

2004-12-31

13.84%

2004-09-30

12.81%

2004-06-30

12.45%

2004-03-31

12.68%

2003-12-31

12.61%

2003-09-30

12.42%

2003-06-30

11.81%

Return on Invested Capital (ROIC): 3.72%

BDX Return on Invested Capital (ROIC)

BDX Average Return on Invested Capital (ROIC) Chart

BDX Current vs Average Return on Invested Capital (ROIC) Chart

BDX Return on Invested Capital (ROIC) Metrics

BDX Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

BDX Return on Invested Capital (ROIC) History

Related Metrics